| Q50057258 | Cystic fibrosis transmembrane conductance regulator-emerging regulator of cancer. |
| Q39585468 | Down-regulation of miR-23b may contribute to activation of the TGF-β1/Smad3 signalling pathway during the termination stage of liver regeneration |
| Q53026426 | HES1 as an independent prognostic marker in esophageal squamous cell carcinoma. |
| Q34788468 | HES1, a target of Notch signaling, is elevated in canine osteosarcoma, but reduced in the most aggressive tumors |
| Q33742561 | Imperfect centered miRNA binding sites are common and can mediate repression of target mRNAs |
| Q38046769 | Ion channels/transporters as epigenetic regulators? -a microRNA perspective |
| Q99711998 | Loss of HES-1 Expression Predicts a Poor Prognosis for Small Intestinal Adenocarcinoma Patients |
| Q35685793 | MicroRNA-23b Inhibits the Proliferation and Migration of Heat-Denatured Fibroblasts by Targeting Smad3 |
| Q40867295 | MicroRNA-9 promotes proliferation of leukemia cells in adult CD34-positive acute myeloid leukemia with normal karyotype by downregulation of Hes1. |
| Q35809571 | MicroRNAs in opioid pharmacology |
| Q38038648 | MicroRNAs in pancreas development |
| Q21131252 | Non-Coding RNAs Regulating Morphine Function: With Emphasis on the In vivo and In vitro Functions of miR-190 |
| Q30484251 | Podocyte-specific loss of functional microRNAs leads to rapid glomerular and tubular injury |
| Q37039055 | Post-transcriptional regulation of mouse mu opioid receptor (MOR1) via its 3' untranslated region: a role for microRNA23b |
| Q37748390 | Small RNAs have a big impact on regeneration |
| Q38258638 | The miRNA23b-regulated signaling network as a key to cancer development--implications for translational research and therapeutics |